TIMBERLY GILFORD: Open Payments
NPI 1346560638 · PASADENA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 59 payments from 13 companies in 2025. Trend: 2023 $1,323 · 2024 $949 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $423 |
| AstraZeneca Pharmaceuticals LP | 9 | $319 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $143 |
| Exact Sciences Corporation | 5 | $116 |
| Lilly USA, LLC | 5 | $88 |
| Amgen Inc. | 4 | $69 |
| Edwards Lifesciences Corporation | 1 | $55 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Dexcom, Inc. | 2 | $40 |
| Gilead Sciences, Inc. | 2 | $34 |
Products named: Wegovy, AIRSUPRA, Kerendia, FARXIGA, Cologuard Collection Kit, Ozempic, Rybelsus, MOUNJARO.
Industry payments across TX — which companies pay providers there.
